Cell death is generally believed to occur either by accidental, lytic necrosis or by programmed cell death, that is, apoptosis. The initiation and execution of cell death, however, is far more complex and includes pathways like caspase-independent apoptosis or actively triggered necrosis. In this study, we investigated the mechanisms of cell death induced by arsenic trioxide (arsenite, As 2 O 3 ), a clinically efficient agent in anticancer therapy. As 2 O 3 -induced cell death coincides with cytochrome c release, facilitates mitochondrial permeability transition and is sensitive to inhibition by Bcl-x L , indicating that cell demise is regulated through the mitochondrial apoptosis pathway. Nevertheless, only little caspase-3 activation was observed and As 2 O 3 -induced cell death was only weakly obstructed by the broad spectrum caspase inhibitor z-VAD-fmk. Moreover, disruption of caspase-9 or -2 failed to decrease the amount of As 2 O 3 -mediated cell death. Interestingly, As 2 O 3 -induced cell death had a predominantly necrosis-like phenotype as assessed by Annexin-V/propidium iodide staining and LDH release. Finally, blocking glutathione synthetase by buthionine sulfoximine enhanced the As 2 O 3 -mediated necrosis-like cell death without increasing caspase-3 cleavage. As 2 O 3 does, however, not directly inhibit caspases, but appears to interfere with caspase activation. Altogether, our data clearly delineate a mode of As 2 O 3 -triggered cell death that differs considerably from that induced by conventional anticancer drugs. These findings may explain the capability of As 2 O 3 to efficiently kill even chemoresistant tumor cells with disturbed apoptosis signaling and caspase activation, a frequent finding in malignancy.
Introduction
Apoptosis and necrosis are two forms of cell death with distinct biochemical and morphological features. While apoptotic cells are defined in most cases by fragmented nuclei with condensed chromatin and formation of apoptotic bodies, necrotic cells are characterized by mitochondrial swelling and loss of plasma membrane integrity without severe nuclear damage (Wyllie et al., 1980) . Mechanisms involved in necrosis have hardly been elucidated. In contrast, events leading to apoptotic cell death have been described to a greater extent (Kroemer and Reed, 2000) . While apoptosis results in rapid phagocytosis and elimination of the affected cell, necrosis leads to spilling of cellular contents resulting in inflammation and tissue damage.
In contrast to necrosis, apoptosis is mediated by caspases that are activated either by the extrinsic pathway or the intrinsic apoptosis pathway that is mediated either via the mitochondria or the endoplasmic reticulum. The extrinsic pathway is initiated by the ligation of a death receptor, for example, CD95 (Fas, APO-1) or the TRAIL receptors, and the subsequent assembly of the death-inducing signaling complex (DISC) that recruits and activates caspase-8 or -10 Peter and Krammer, 2003) . In contrast, death-receptor-independent stimuli like growth-factor deprivation or anticancer drugs induce apoptosis through the mitochondrial pathway. Here, loss of mitochondrial transmembrane potential (DC m ) accompanies the release of cytochrome c into the cytosol. This triggers apoptosome formation and activation of the caspase cascade that is enhanced by Smac/Diablo and Omi/HtrA2, which are also released from mitochondria during apoptosis (van Loo et al., 2002) .
Arsenic trioxide (As 2 O 3 ), a common environmental toxin, has successfully been employed in patients with acute promyelocytic leukemia (APL) (Shen et al., 1997; Soignet et al., 1998; Niu et al., 1999) . APL cells typically express the PML-RARa (promyelocytic leukemia gene product-retinoic acid receptor a) fusion protein. In line with this, degradation and targeting of PML to nuclear bodies was initially suggested to be the key event in As 2 O 3 -induced cell death . Nevertheless, this has been questioned as As 2 O 3 is capable of killing PML/RARa negative cell lines and cells from PML knockout mice (Akao et al., 1998; Wang et al., 1998; Zhang et al., 1998; Zhu et al., 1999) . Several reports have demonstrated the participation of the mitochondrial apoptosis pathway in As 2 O 3 -induced cell death (Chen et al., 1998; Larochette et al., 1999) . In this vein, activation of APAF-1, caspases-3 and -9 and cleavage of Bid were postulated to mediate As 2 O 3 -induced cell death (Perkins et al., 2000) .
In the present study, we analysed the action of As 2 O 3 in more detail resulting in some intriguing findings that challenge the current concept of cell death induced by As 2 O 3 . While As 2 O 3 -mediated cell death involved the mitochondrial death pathway, we consistently observed only rather limited activation of the caspase-3 upon As 2 O 3 -treatment when compared with other chemotherapeutic drugs Radetzki et al., 2002; von Haefen et al., 2003; Prokop et al., 2003) or death receptor ligation Schmelz et al., 2004) , ceramide , Smac/ Diablo (Hasenja¨ger et al., 2004) or endogenous activators of the intrinsic apoptosis pathway such as p14 ARF (Hemmati et al., 2002) or BH3-only proteins such as Nbk (Gillissen et al., 2003) . This rather weak activation of the effector caspase-3 by arsenite was, however, not due to a direct inhibitory effect of As 2 O 3 on caspases. Furthermore, the broad-spectrum caspase inhibitor z-VAD-fmk as well as knockout of caspase-9 or -2 failed to prevent As 2 O 3 -induced cell death. Thus, As 2 O 3 -triggered cell death proceeds largely independent of caspase activity. Interestingly, As 2 O 3 -mediated cell death had a predominantly necrosis-like phenotype. These findings may at least in part explain the clinical efficiency of As 2 O 3 not only in APL but also in other malignancies that are refractory to conventional cytotoxic drugs.
Results
Arsenite induces necrotic cell death that is affected only marginally by the broad-spectrum caspase inhibitor z-VAD-fmk As 2 O 3 efficiently induces cell death in a number of cell lines from APL and other hematologic malignancies. To investigate the molecular mechanisms of As 2 O 3 -induced cell death, we cultured the APL cell line NB4 (Lanotte et al., 1991) with increasing concentrations of As 2 O 3 for 24 or 48 h. Cells were either cultured in As 2 O 3 alone or were treated with As 2 O 3 in the presence of 20 or 40 mM of the broad spectrum caspase inhibitor z-VAD-fmk. Subsequently, cell death was assessed by measuring hypodiploid DNA content (Figure 1a ). Alternatively, cell death was quantified by staining cells with Annexin-V-FITC/propidium iodide (PI). Positivity for Annexin-V-FITC in the absence of PI staining (Figure 1b ) is a characteristic of apoptosis, while positivity for PI (Figure 1c) , that is, membrane damage, indicates a necrotic type of cell death (Vermes et al., 1995) . Only moderate amounts of cell death, both apoptosis-like and necrosis-like occurred after 24 h of culture left panel) . In contrast, 48 h of treatment with As 2 O 3 resulted in a substantial increase of necrosis-like cell death ( Figure 1c , right panel), while apoptotic cell death as determined by Annexin-V-FITC positivity and PI negativity increased to a lesser degree (Figure 1b, right panel) . This necrosis like death was associated with genomic DNA fragmentation (Figure 1a, right panel) . Addition of z-VAD-fmk only partially blocked cell death as detected by either method (Figure 1a-c) . Culture in the presence of z-VAD-fmk partially inhibited apoptotic death whereas necrotic death was only slightly affected. As a positive control for apoptosis inhibition by z-VAD-fmk, NB4 cells were treated with paclitaxel as this compound was shown previously to depend on caspase-3 and -8 (von Haefen et al., 2003) . There, increasing doses of z-VAD-fmk strongly interfered with genomic DNA fragmentation and exposure of Annexin-V-FITC binding phosphatidylserine epitopes on PI negative cells (Figure 1d ). These data suggest that As 2 O 3 induces a caspase-independent mode of cell death that occurs by necrosis.
As 2 O 3 -induced cell death occurs via the mitochondrial pathway
To further investigate this mechanism of arsenite induced cell death, we analysed the mitochondrial apoptosis pathway in As 2 O 3 -treated cells. Previous results obtained in human myeloid cell lines and cellfree systems indicated that As 2 O 3 acts through the intrinsic pathway (Larochette et al., 1999; Perkins et al., 2000) . To address this mechanism in the present context, we exposed Bcl-x L -transfected BJAB Burkitt-like lymphoma cells (BJAB-Bcl-x L ) to arsenite. As in the NB4 system, arsenite preferentially induced necrotic death as evidenced by the occurrence of PI positive cells. Bcl-x L overexpression efficiently blocked this cell death in response to treatment with As 2 O 3 (Figure 2 ). Similar results were obtained in Jurkat cells stably expressing Bcl-2 or Bcl-x L (data not shown).
Measurement of the mitochondrial membrane potential (DC m ) by use of the cationic dye JC-1 showed that arsenite induces mitochondrial permeability transition. Breakdown of DC m was time-dependent and occurred as early as 12 h after As 2 O 3 exposure (Figure 3a) . Thus, mitochondrial damage preceded the induction of cell death suggesting a role in As 2 O 3 -triggered cytotoxicity.
To corroborate these findings, we assessed the release of cytochrome c into the cytosol by Western blot analysis. BJAB cells were incubated with medium or As 2 O 3 for 24 h. As a positive control, cells were exposed to epirubicin, which has been shown to induce cell death through the mitochondrial pathway of apoptosis in a Bax-dependent manner (Hemmati et al., 2002; von Haefen et al., 2002) . Cytochrome c release into the cytosol was repeatedly detected in cells treated with As 2 O 3 or epirubicin for 24 h, while no cytosolic cytochrome c was detectable in the medium controls (Figure 3c ). Thus, both epirubicin and As 2 O 3 initiate the mitochondrial apoptosis pathway and cytochrome c release, which is a key event for the assembly of the apoptosome and caspase-9 and -3 activation. Treatment of BJAB mock cells with As 2 O 3 or epirubicin triggered cell death to a similar extent as determined by measuring genomic DNA fragmentation (Figure 3b ). Caspase-3 processing to the active p17 subunit was, however, far less pronounced in case of As 2 O 3 as compared to epirubicin-treated cells (Figure 3d) .
To determine the functional role of caspase activation in cell death induced by arsenite, BJAB cells were treated for 24 h with either medium or As 2 O 3 in the presence or absence of 10 mM z-VAD-fmk. In accordance with the data obtained in NB4 cells, addition of the broad range caspase inhibitor did not impair cell death triggered by As 2 O 3 (Figure 3e ). In contrast, z-VAD-fmk efficiently blocked apoptosis mediated by an agonistic anti-CD95 antibody, which served as a positive control in this setting (Figure 3e ). In addition, z-VAD-fmk did not inhibit As 2 O 3 -induced mitochondrial permeability shift transition (data not shown). Taken together, As 2 O 3 induces cell death via activation of the mitochondrial apoptosis pathway without significant caspase-3 activation. Furthermore, activation of caspases that can be blocked by the broad spectrum inhibitor z-VAD-fmk appears to be dispensable for the execution of As 2 O 3 -induced cell death in a panel of cell lines from distinct hematologic malignancies, that is, myeloid NB4, B-lymphoid BJAB and T-lymphoid Jurkat cells.
Reduced caspase activation in cells treated with As 2 O 3 can be restored in vitro Since As 2 O 3 treatment triggered only weak caspase-3 cleavage, we examined the possibility that As 2 O 3 might directly inhibit caspase enzymatic activity. To this end, we prepared extracts from BJAB cells treated for 24 h with arsenite or epirubicin and determined caspase activity by measuring the cleavage of the colorimetric substrate Ac-DEVD-pNA. The cell extracts were incubated in the presence or absence of exogenous dATP and cytochrome c. Epirubicin induced 54% of maximal caspase-3-like activity in the absence of supplemented dATP and cytochrome c. In contrast, treatment with As 2 O 3 induced only 15% of maximal DEVDase activity (Figure 4a ). Supplementation with dATP and cytochrome c induced similar caspase-3-like (Figure 4c ). Thus, the limited activation of caspase-3 during As 2 O 3 -induced cell death was not due to a direct inhibitory effect on caspase activity.
Inhibition of glutathione synthetase augments caspase-independent cell death by As 2 O 3
The generation of reactive oxygen species (ROS) and subsequent loss of mitochondrial membrane potential have been suggested as potential mechanism in various forms of cell death. An important antioxidant counteracting these processes is glutathione. Adding buthionine sulfoximine (BSO), an inhibitor of the glutathione synthetase, to As 2 O 3 -treated BJAB mock cells markedly increased As 2 O 3 -mediated cell death (Figure 5a ). BSO alone did, however, not influence cell viability. Addition of BSO to the As 2 O 3 -exposed cultures led to a pronounced increase of the number of PI-positive cells, when assessed by PI and annexin-V-FITC staining. This indicates that ROS and glutathione depletion are critically involved in the necrosis-like cell death induced by arsenite. Likewise, BSO induced a drastic increase in arsenite-triggered lactate dehydrogenase (LDH) release into the supernatant, indicating membrane damage and necrotic cell death (Figure 5b ). Notably, cell culture with arsenite together with BSO also induced a substantial increase of cytochrome c release into the cytosol with a concomitant decrease in the mitochondrial fraction ( Figure 5c ). Nevertheless, these effects of a combined treatment with arsenite and BSO were not accompanied by an increase of caspase-3 processing to the active p17 subunit (Figure 5d ). Thus, blocking glutathione synthesis acts on the caspase-3 independent, necrosis-like cell death mediated by As 2 O 3 .
Caspase-9 and -2 are dispensable in As 2 O 3 -triggered cell death
So far, we demonstrated that caspase activation is not required for arsenite induced cell death by necrosis.
As z-VAD-fmk, however, does not efficiently block (a) BJAB cells were incubated for 24 h with medium alone, arsenite (2 or 4 mM) or epirubicin (1 mg/ml). Cell extracts were prepared and incubated for 1 h at 371C with Ac-DEVD-pNA and DEVDase activity was determined in a colorimetric assay. Caspase-3-like activity is given as the percentage of total enzyme activity assuming that addition of cytochrome c/dATP yields 100% activation. Means7s.d. from three experiments are shown. (b) Cell extracts were incubated in the presence ( þ ) or absence (À) of cytochrome c/dATP with buffer alone or buffer containing 5 mM As 2 O 3 for 1 h at 371C. DEVDase activity was assessed as described above and substrate cleavage (extinction) was measured at 405 nm. The high extinction at t ¼ 0 in the presence of cytochrome c/dATP is due to absorbance of cytochrome c at 405 nm. (c) Caspase-3-like activity is given as the percentage of enzyme activity measured in cell extracts in the absence of As 2 O 3 . Mean results of three experiments7s.d. are shown. In the absence of As 2 O 3 , caspase-3-like activity was 0.2170.013 mU/ml, and in the presence of 5 mM As 2 O 3 caspase-3-like activity was 0.2270.01 mU/ml
Programmed necrosis by arsenic trioxide C Scholz et al caspase-2, we choose to investigate the role of caspase-2 and to further address the function of the apoptosome in As 2 O 3 -mediated cell demise. To this end, we employed immortalized murine fibroblasts deficient for caspase-9 (3T9 caspase-9 À/À) or caspase-2 (3T9 caspase-2 À/À) and compared them to congeneic wild-type fibroblasts (3T9 wt). All lines were treated with increasing concentrations of arsenite for 48 h and cell death was assessed by staining cells with Annexin-V-FITC and PI. As expected, the deletion of neither caspase-9 nor -2 substantially decreased the amount of overall cell death, that is, the sum of PI positive and Annexin-V-FITC positive/PI negative cells (Figure 6a ). Disruption of caspase-9 expression was, however, related to a decreased rate of apoptosis (Figure 6b ) while loss of caspase-2 had no impact on arsenite-induced apoptosis, that is, the occurrence of Annexin-V-FITC positive/PI negative cells. Notably, loss of caspase-2 or -9 facilitated a slight increase of necrotic death as determined by measuring percentages of PI positive cells, that is, a necrosis-like phenotype, especially at low arsenite concentrations (Figure 6c ).
Discussion
Anticancer therapies exert their cytotoxic activity by triggering tumor cell apoptosis. This occurs either through DNA damage or the targeting of structures critically involved in cell cycle regulation and results in the activation of cell cycle checkpoint arrest programs and induces apoptosis when repair fails. The vast majority of anticancer drugs and ionizing irradiation induce apoptotic cell death through the mitochondrial pathway of apoptosis in a death receptor-independent manner Mrozek et al., 2003) . Here, we show that As 2 O 3 , a reagent successfully employed in the treatment of APL and recently also in solid tumors, induces a regulated form of necrotic death. We demonstrate that arsenite-mediated cell death is blocked by Bcl-x L , suggesting a role for the mitochondrial pathway of apoptosis. Contrary to our expectations, however, arsenite-induced cell death does not appear to rely on caspases, as only weak caspase-3 processing was observed, and cell death could not be inhibited by z-VAD-fmk. To further corroborate this notion of independence from caspase activation, we employed immortalized fibroblasts from caspase-9 or -2 knockout mice. While arsenite-induced apoptosis was slightly impaired in caspase-9 knockout cells, none of these genotypes inhibited the rate of overall cell death and induction of necrotic death. Thus, caspases are dispensable for induction of necrosis-like death, which is the dominant form of cell death induced by arsenite.
Until lately, cell death in general has been considered to be either due to caspase-dependent apoptosis or to necrotic cell lysis. Following this dichotomy, most authors concentrated on signs of apoptosis often assuming caspase-dependency when investigating As 2 O 3 -mediated cell death (Chen et al., 1998; Zhu et al., 1999; Perkins et al., 2000) . Recent data indicate, however, that cell death is more complex. Apart from caspase-dependent apoptosis, alternative death mechanisms, for example, caspase-independent apoptosis and necrosis-like programmed cell death have been described (Blagosklonny, 2000; Leist and Jaattela, 2001; Zong et al., 2004) .
Our present data demonstrate that As 2 O 3 -induced cell death is regulated through a Bcl-x L -sensitive mechanism, involves activation of mitochondria and cytochrome c release, but activates mainly caspase-independent mechanisms for the execution of cell death that culminate in necrotic cell death. In accordance with this model, another group detected As 2 O 3 -mediated cleavage of caspase-3 in some but not all cell lines tested, although Programmed necrosis by arsenic trioxide C Scholz et al all cells were sensitive to As 2 O 3 -mediated cell death (Zhu et al., 1999) . Moreover, As 2 O 3 -induced cell demise was not blocked in cells deficient for caspase-2 or -9. While caspase-9 is part of the apoptosome and therefore plays a key role during the mitochondrial pathway of apoptosis (Hu et al., 1999; Saleh et al., 1999; Zou et al., 1999) , caspase-2 is currently discussed as an initiator caspase that might respond to DNA damage and activates the mitochondrial apoptosis machinery (Troy and Shelanski, 2003; Norbury and Zhivotovsky, 2004; Robertson et al., 2004) . Nevertheless, our present data delineate that caspases appear to be dispensable for induction of cell death by As 2 O 3 .
The mechanism how arsenite induces this caspaseindependent death remains enigmatic. Mitochondrial factors appear to play, however, a critical role as necrotic cell death induced by arsenite can be blocked by Bcl-x L . Candidates for induction of caspase independent death include the apoptosis-inducing factor (AIF), endonuclease G (van Loo et al., 2002), or ROS (Gottlieb et al., 2000) . Inhibition of the glutathione synthetase has been reported to result in an impaired capacity to detoxify ROS. In fact, production of ROS can be suppressed by Bcl-x L and inhibition of glutathione synthesis by BSO enhanced arsenite induced necrotic cell demise as reported previously in arsenite-induced apoptosis Kitamura et al., 2000) . Functional data corroborate that generation of ROS is a key feature of arsenite-mediated cell death (Wang et al., 1996; Chen et al., 1998; Jing et al., 1999; Yang et al., 1999) . Oxidative stress induces cell death through mitochondria, where the pursuit of an apoptotic or a necrotic pathway depends on the strength of the insult and the availability of functional caspases (Fernandes and Cotter, 1994; Fiers et al., 1999) . Nevertheless, failure of additional properties of the mitochondria, that is, ADP/ATP exchange , might be involved in triggering cell death. In fact, arsenite triggers loss of cellular ATP and this is enhanced by BSO (data not shown). This might also explain the observation that caspase activation is less pronounced in cell death induced by arsenite as compared with conventional anticancer drugs. Formation of the apoptosome is energy dependent and ATP depletion might interfere with apoptosome formation (Hu et al., 1999; Saleh et al., 1999) . This model is indirectly supported by our finding that arsenite interferes with caspase activation but does not inhibit caspase enzyme activity in a cell-free system as DEVDase activity could be induced in extracts from As 2 O 3 -treated cells upon addition of exogenous cytochrome c and dATP.
In conclusion, we show that As 2 O 3 induces necrotic cell death through a regulated, Bcl-x L -sensitive mitochondrial pathway that is largely caspase-independent. The capability of inducing cell death even in the absence of the caspase cascade may be a key feature of As 2 O 3 and explains its efficiency to trigger cell death in a variety of drug-resistant cell types including, in particular, tumor cells with defects in caspase activation. Finally, our data add new aspects to the notion that necrosis and apoptosis are not two exclusive forms of cell death, but may occur within the same cell in response to a single stimulus.
Material and methods

Reagents
As 2 O 3 and BSO were purchased from Sigma-Aldrich (Taufkirchen, Germany). As 2 O 3 was dissolved in 1 M NaOH to generate a 5-mM stock solution that was serially diluted in RPMI 1640 supplemented with 100 U/ml penicillin, 100 mg/ml streptomycin, 4 mM L-glutamine and 10% fetal calf serum (GibcoBRL, Life Technologies, Karlsruhe, Germany). The maximum concentration of NaOH present in culture medium had no influence on cell growth, cell death, ATP content, cytochrome c release, caspase-3 cleavage or caspase activity in the cell lines employed (data not shown). BSO was dissolved in PBS as a 5 mM stock solution. Addition of BSO alone at the maximum concentration of 100 mM neither induced cell death as measured by annexin-V-FITC (fluorescein isothiocyanate)/PI staining, LDH release nor did BSO influence ATP content, cytochrome c release or caspase-3 activation (data not shown). Epirubicin was purchased from Pharmacia Upjohn (Erlangen, Germany) and diluted in complete medium to create a 2 mg/ml stock solution. The irreversible, broad caspase inhibitor z-VADfmk (in which fmk stands for fluoromethylketone) was obtained from Calbiochem-Novabiochem (Bad Soden, Germany). Cells were preincubated with z-VAD-fmk at a final concentration of 10 to 40 mM 1 h before the addition of cytotoxic agents.
Cell lines
NB4 cells (Lanotte et al., 1991) were a kind gift by Dr H Drexler, Braunschweig, Germany. BJAB cells expressing Bcl-x L (BJAB Bcl-x L ) (Fulda et al., 2001 ) were a generous gift by Dr S Fulda, University of Ulm, Germany. Murine fibroblasts immortalized by the 3T9 protocol and deficient for caspase-9 (3T9 caspase-9 À/À) or caspase-2 (3T9 caspase-2 À/À) (Marsden et al., 2002) were kindly provided by Dr A Strasser, WEHI Institute, Melbourne, Australia. Prior to the experiments, all cell lines were cultured overnight in complete medium at a concentration of 4 Â 10 5 to allow logarithmic growth. Subsequently, cells were seeded at a density of 1 Â 10 5 cells/ml and cultured with medium alone, As 2 O 3 , epirubicin, paclitaxel, agonistic anti-CD95 antibody (anti-APO-1 IgG 3 (Dhein et al., 1992) ) or the control antibody (FII23c IgG3 (Dhein et al., 1992) ) at the indicated concentrations and time periods.
Measurement of cell death by annexin-V-FITC and PI staining
Cell death was determined by staining cells with annexin-V-FITC and counterstaining with PI. Annexin-V-FITC binds to phosphatidylserine (PS) on the outer leaflet of the plasma membrane. PI is excluded by cells with intact membranes. PI positivity is, therefore, a sign of necrosis, whereas cells positive for annexin-V, but negative for PI are generally defined as apoptotic (Vermes et al., 1995) . Briefly, cells were washed twice with cold PBS and resuspended in buffer (10 mM N-[2-hydroxyethyl]piperazin-N 0 -3[propansulfonicacid]/NaOH, pH 7.4, 140 mM NaCl, 2.5 mM CaCl 2 ) at 1 Â 10 6 cells/ml. Next, 5 ml of annexin-V-FITC (BD PharMingen, Heidelberg, Germany) and 10 ml PI (20 mg/ml, Sigma-Aldrich) were added. Analyses were performed using a FACScan (Becton Dickinson, Heidelberg, Germany) and CellQuest analysis software.
Assessment of genomic DNA fragmentation by flow cytometric measurement of nuclear DNA content To measure genomic DNA fragmentation, nuclear DNA content was determined by flow cytometry as described (Daniel et al., 1998) . Briefly, 10 5 cells were pelleted in a 96-well U-bottom plate. The pellet was then gently resuspended with 200 ml buffer (50 mg/ml PI, 0.1% sodium citrate, 0.1% Triton X-100) and incubated overnight in the dark at 41C. Genomic DNA content was determined using a FACScan flow cytometer (Becton Dickinson, Heidelberg, Germany) and CellQuest analysis software. Nuclei displaying a hypodiploid, sub-G1 DNA content were identified as apoptotic. Cell debris, characterized by low forward and side scatter values, was excluded from the analysis.
Assessment of cell death and cell lysis by the release of LDH activity LDH activity was determined in a colorimetric assay (Roche Diagnostics, Mannheim, Germany) based on the generation of NADH by reduction of lactate and NADH-dependent conversion of 2-[4-Iodophenyl]-3-[4-nitrophenyl]-5-phenyltetrazolium chloride (INT) by diaphorase. Briefly, cells were seeded at 1 Â 10 5 cells/ml and cultured with the different cytotoxic reagents. After the indicated times cells were pelleted by centrifugation at 300 g for 5 min. Then, 20 ml of supernatant were mixed with 80 ml PBS and 100 ml reaction mixture, and incubated for 30 min at room temperature in the dark. Subsequently, absorbance was measured in a microplate reader (SLT Labinstruments, Crailsheim, Germany) at 490 nm. To assess maximal LDH activity, cells were lysed with 0.1% Triton X-100 and processed as described above. To measure basal levels of LDH release, 20 ml of supernatant from cells cultured in medium only were used. Relative values for LDH activity were calculated as follows: (LDH release from treated cells minus spontaneous release) divided by (maximal LDH release minus spontaneous release).
Assessment of mitochondrial membrane potential
Cells treated with As 2 O 3 at various concentrations were collected by centrifugation at 300 g, 41C for 5 min. Mitochondrial permeability transition was determined by staining the cells with 5,5 0 ,6,6 0 -tetrachloro-1,1 0 ,3,3 0 -tetraethyl-benzimidazolylcarbocyanin iodide (JC-1; Molecular Probes, Leiden, The Netherlands) as described (Reers et al., 1995) . Briefly, 1 Â 10 5 cells were resuspended in 500 ml phenol red-free RPMI 1640 without supplements. JC-1 (2.5 mg/ml) was added and cells were gently shaken for 30 min at 371C. Controls were incubated in the absence of JC-1. Cells were then harvested by centrifugation, washed in PBS and resuspended in 200 ml PBS at 41C. Mitochondrial permeability transition, defined as cells with decreased fluorescence due to lower membrane potential, was quantified by flow cytometry.
Immunoblotting
After treatment under the respective conditions, cells were washed twice with PBS and lysed in buffer containing 10 mM Tris/HCl pH 7.5, 300 mM NaCl, 1% Triton X-100, 2 mM MgCl 2 , 5mM EDTA, 1 mM pepstatin, 1 mM leupeptin, and 0.1 mM phenylmethylsulfonyl fluoride. Protein concentration was determined using the bicinchoninic acid assay (Pierce, Rockford, IL, USA), and equal amounts of protein (usually 20 mg per lane) were separated by SDS-PAGE. Immunoblotting was performed as described . Membranes (Schleicher & Schuell, Dassel, Germany) were swollen in CAPS-buffer (10 mM 3-[cyclohexylamino]propane-1-sulfonic acid, pH 11, 10% MeOH), and blotting was performed at 1 mA/cm 2 for 1 h in a transblot SD cell (BioRad, Munich, Germany). The membrane was blocked for 1 h in PBST (PBS, 0.05% Tween-20) containing 3% non-fat dry milk and incubated with the primary antibody for 1 h. As primary antibodies either a rabbit anti-human-caspase-3 or a mouse monoclonal (IgG 2b ) anti-human-cytochrome c antibody (BD PharMingen, Heidelberg, Germany) were employed. After washing in PBST, the respective secondary antibodies conjugated to horse radish peroxidase (Promega, Madison, WI, USA) were applied for 1 h. Finally, the membrane was washed in PBST, and protein bands were detected using the enhanced chemiluminescence system (Amersham Buchler, Braunschweig, Germany). To detect cytochrome c released from mitochondria into the cytosol, cells were pelleted by centrifugation at 300 g for 5 min and resuspended in lysis buffer containing 20 mM HEPES pH 7.4, 10 mM KCl, 2 mM MgCl 2 , 1mM EDTA, 100 mM DTT, 0.1 mM PMSF and 0.75 mg/ml digitonin. Following incubation for 30 min on ice, cell lysates were centrifuged at 13 000 g at 41C for 15 min. Supernatants containing cytosolic protein were processed as described above.
Measurement of caspase-3/DEVDase activity
Caspase-3/DEVDase activity was measured as described . Briefly, after incubation with As 2 O 3 or medium alone, cells were washed twice with PBS, resuspended in buffer A containing 20 mM HEPES, pH 7.4, 10 mM KCl, 2 mM MgCl 2 , 1 mM EDTA, 1 mM DTT and incubated on ice for 15 min. Cytosolic extracts were prepared by homogenizing cells through a 21 G Â 1 1/2 needle and cleared by two centrifugation steps at 16 000 g, 41C for 15 min. After incubation in the absence or presence of 10 mM cytochrome c and 1 mM dATP, caspase-3-like activity was measured by mixing 10 ml of the extract, 90 ml of buffer B containing 50 mM HEPES, pH 7.4, 100 mM NaCl, 1 mM EDTA, 0.1% 3-[(3-cholamidopropyl)dimethyl-ammonio]-1-propanesulfonate (CHAPS), 10% sucrose, 5 mM DTT, and 2 ml colorimetric substrate (10 mM Ac-DEVD-pNA in DMSO). Samples were incubated at 371C and the absorbance at 405 nm was measured in a microplate reader every 10 min for 90 min. Caspase-3-like activity is given in percent assuming that addition of cytochrome c/dATP yielded 100% activation.
Alternatively, to assess inhibition of caspase-3 by As 2 O 3 , extracts from cells treated with medium were prepared as described above. Cleared extracts were incubated in the presence of cytochrome c and dATP with buffer B containing increasing amounts of As 2 O 3 (1, 5, 50 or 100 mM) for 1 h at 371C and employed in the caspase assay.
Statistics
All experiments were performed at least three times. Results are expressed as means7s.d.
